HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Consumer Health Changes ‘At Speed Of Instagram’ Drive J&J’s Decision On Separating Businesses

Executive Summary

J&J provided color on plans for standalone consumer health business during a business overview with analysts. Multiple separation pathways are being considered.

You may also be interested in...



Consumers Know Kenvue's Brands, But What About ‘Opportunity To Expand Usage Occasions’?

“That’s what makes this space very attractive, the ability to expand usage occasions to give consumers around the world new opportunities to take care of their health,” says CEO Thibaut Mongon. Some investors aren’t clear on what to expect from company operating entirely in consumer health since spinout from J&J.

Familiar Leadership For J&J's Planned Consumer Spinoff

J&J's current consumer health division head, Thibaut Mongon, will be at the helm of its planned spinout of the business while Paul Ruh will move to the company was CFO. 

J&J Sees Clear But Bumpy Road Ahead For Consumer Health, Personal Care Business Growth

Q1 results arrive with cautionary forecasts on “external challenges” limiting sales and net income growth. Limited availability and higher commodity prices and increased costs for labor, energy and transportation are “pervasive across the enterprise but most notable in consumer health,” says CFO Joseph Wolk.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151970

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel